Ran Nussbaum Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Ran Nussbaum.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Ran Nussbaum. Ran Nussbaum is a Director in ARQULE INC ($ARQL) and a in Eloxx Pharmaceuticals, Inc. ($ELOX) and a Director in Eloxx Pharmaceuticals, Inc. ($ELOX) and a Director in Kite Pharma, Inc. ($KITE) and a Director in UroGen Pharma Ltd. ($URGN).

Over the past year Ran Nussbaum has been an insider in 3 companies. The total value of shares held by Ran Nussbaum in these companies amounts to $117,495.

Ran Nussbaum Director
ARQULE INC
Director
Eloxx Pharmaceuticals, Inc.
Director
Kite Pharma, Inc.
Director
UroGen Pharma Ltd.
$ 117495 The total value of shares held by Ran Nussbaum
Insider Rank

Ran Nussbaum ranks 30,987 out of 350,000 insiders. Go to Insider Ranking to see more.

Address: C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA 90404 CA

Companies in which Ran Nussbaum is an Insider

ARQULE INC

Trading Symbol: ARQL
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ran Nussbaum: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 16 2020
$ARQL Market Capitalization: $96.01M
$ARQL Previous Close: $1.37

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 24x
Sell: 8x
Shares Bought: 9,312,099
Shares Sold: 8,890,121
Share Difference: +421,978
Value Difference: +$167,468,079

Eloxx Pharmaceuticals, Inc.

Trading Symbol: ELOX
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Ran Nussbaum: Director
Holdings: 510,846 shares
Current Value: $117,495
Latest Transaction: Jun 26 2019
$ELOX Market Capitalization: $4.75M
$ELOX Previous Close: $0.23

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 19x
Sell: 0x
Shares Bought: 1,262,600
Shares Sold: 0
Share Difference: +1,262,600
Value Difference: -$12,135,330

Kite Pharma, Inc.

Trading Symbol: KITE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ran Nussbaum: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 05 2017
$KITE Market Capitalization: $2.64B
$KITE Previous Close: $53.32

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Last 3 Months Overview:
Buy: 6x
Sell: 5x
Shares Bought: 14,192
Shares Sold: 14,192
Share Difference: 0
Value Difference: -$679,474

UroGen Pharma Ltd.

Trading Symbol: URGN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ran Nussbaum: Director
Holdings: 0 shares
Latest Transaction: Jun 05 2019

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Ran Nussbaum

Sentiment: All, ARQL, ELOX, KITE, URGN

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 16 2020ARQLARQULE INCNussbaum RanDirectorOption ExerciseD6.2140,000248,4000
Jan 16 2020ARQLARQULE INCNussbaum RanDirectorOption ExerciseD2.4820,00049,6000
Jan 16 2020ARQLARQULE INCNussbaum RanDirectorOption ExerciseD1.1030,00033,0000
Jan 16 2020ARQLARQULE INCNussbaum RanDirectorSellU20.008,611172,22008.6 K to 0 (-100.00 %)
Jan 16 2020ARQLARQULE INCNussbaum RanDirectorSellU20.0036,923738,460036.9 K to 0 (-100.00 %)
Jan 16 2020ARQLARQULE INCNussbaum RanDirectorSellU20.002,088,81641,776,32002.1 M to 0 (-100.00 %)
Jan 16 2020ARQLARQULE INCNussbaum RanDirectorSellU20.004,290,55085,811,00004.3 M to 0 (-100.00 %)

View all Ran Nussbaum insider transactions.